# Augmenting Cerebral Blood Flow in Acute Ischemic Stroke

Study · id `cardio:ct-nct06911385` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06911385](<https://clinicaltrials.gov/study/NCT06911385>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06911385

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT06911385. Allocation not applicable; no masking; primary purpose treatment. Start 2026-09-15 (anticipated); primary completion 2027-05-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT06911385, source copy `cardio:ctgov-nct06911385-2026-08-13`, retrieved 2026-10-26)
- Planned start: 2026-09-15 (anticipated) (ClinicalTrials.gov record NCT06911385, source copy `cardio:ctgov-nct06911385-2026-08-13`, retrieved 2026-10-26)
- Primary completion: 2027-05-31 (anticipated) (ClinicalTrials.gov record NCT06911385, source copy `cardio:ctgov-nct06911385-2026-08-13`, retrieved 2026-10-26)
- Completion: 2027-05-31 (anticipated) (ClinicalTrials.gov record NCT06911385, source copy `cardio:ctgov-nct06911385-2026-08-13`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06911385-2026-08-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Augmenting Cerebral Blood Flow in Acute Ischemic Stroke
- Condition: Stroke
- Intervention (Device): Arm Remote Ischemic Conditioning plus Pneumatic Compression lower limb
- Lead sponsor: University of Alberta
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Alberta (`cardio:org-university-of-alberta`)

## Provenance

Content hash: 2fcf7e56f1eed44421349e79d5ba5d04c59269391f3ceddc586a1ae34147689c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
